| __timestamp | Exelixis, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 50829000 | 4042025 |
| Thursday, January 1, 2015 | 57305000 | 5279557 |
| Friday, January 1, 2016 | 116145000 | 8073913 |
| Sunday, January 1, 2017 | 159362000 | 44864073 |
| Monday, January 1, 2018 | 206366000 | 53488904 |
| Tuesday, January 1, 2019 | 228244000 | 65896361 |
| Wednesday, January 1, 2020 | 293355000 | 69968267 |
| Friday, January 1, 2021 | 401715000 | 92047281 |
| Saturday, January 1, 2022 | 459856000 | 131819000 |
| Sunday, January 1, 2023 | 542705000 | 87501000 |
| Monday, January 1, 2024 | 492128000 |
Unleashing insights
In the competitive landscape of biotechnology, strategic spending on Selling, General, and Administrative (SG&A) expenses can be a key differentiator. From 2014 to 2023, Exelixis, Inc. and Pharming Group N.V. have shown distinct patterns in their SG&A expenditures. Exelixis, Inc. has consistently increased its SG&A spending, growing by over 900% from 2014 to 2023. This reflects a robust investment in scaling operations and market presence. In contrast, Pharming Group N.V. has seen a more modest increase of approximately 2,000% over the same period, indicating a more conservative approach. Notably, in 2022, Pharming Group N.V. reached its peak SG&A spending, marking a significant 226% increase from 2014. These trends highlight the differing strategies of these biotech firms in navigating market challenges and opportunities.
SG&A Efficiency Analysis: Comparing AstraZeneca PLC and Pharming Group N.V.
Who Optimizes SG&A Costs Better? Pfizer Inc. or Pharming Group N.V.
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Exelixis, Inc.
Who Optimizes SG&A Costs Better? BioMarin Pharmaceutical Inc. or Pharming Group N.V.
SG&A Efficiency Analysis: Comparing Exelixis, Inc. and Alkermes plc
Cost Management Insights: SG&A Expenses for Exelixis, Inc. and CRISPR Therapeutics AG
SG&A Efficiency Analysis: Comparing Exelixis, Inc. and Soleno Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Exelixis, Inc. or Iovance Biotherapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Pharming Group N.V. and Axsome Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Pharming Group N.V. and Opthea Limited
Breaking Down SG&A Expenses: Pharming Group N.V. vs ACADIA Pharmaceuticals Inc.
Who Optimizes SG&A Costs Better? Pharming Group N.V. or Agios Pharmaceuticals, Inc.